Avoro Capital Advisors LLC

13F Holdings History for Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)

Symbol: GLUE on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 3.73M shares
Security Ownership: 6.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Avoro Capital Advisors LLC ownership in Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

2025-08-14 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.73M shares of Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE). This represents 6.1% percent ownership of the company. In their previous filing dated 2025-02-14, Avoro Capital Advisors LLC had reported owning 4.35M shares, indicating a decrease of -14.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Avoro Capital Advisors LLC	6.1%	-14.3%	$18M	3.73M	-620,000	-14.3%	$4.83	13G/A	6/30/2025	14 Aug 2025 07:10:41
Avoro Capital Advisors LLC	7.1%		$18.3M	4.35M			$4.22	13G/A	12/31/2024	14 Feb 2025 09:30:18

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.29%	-0.07%	$16.8M	3.73M	-920,548	-19.8%	$4.51	Q2 2025
3/31/2025	0.34%	+0.02%	$21.6M	4.65M	+300,548		$4.64	Q1 2025
12/31/2024	0.43%	-0.14%	$30.2M	4.35M	-1,445,236	-25%	$6.94	Q4 2024
9/30/2024	0.45%	+0.1%	$30.7M	5.79M	+1,255,236	+27.7%	$5.30	Q3 2024
6/30/2024	0.23%		$17M	4.54M			$3.74	Q2 2024
3/31/2024	0.37%		$32M	4.54M			$7.05	Q1 2024
12/31/2023	0.35%		$25.6M	4.54M			$5.65	Q4 2023
9/30/2023	0.34%		$21.7M	4.54M			$4.79	Q3 2023
6/30/2023	0.42%	+0.02%	$31.1M	4.54M	+210,000	+4.86%	$6.85	Q2 2023
3/31/2023	0.5%		$33.7M	4.33M			$7.79	Q1 2023
12/31/2022	0.49%	+0.11%	$32.9M	4.33M	+961,667	+28.6%	$7.61	Q4 2022
9/30/2022	0.51%	+0.01%	$27.5M	3.36M	+51,797	+1.56%	$8.17	Q3 2022
6/30/2022	0.63%	+0%	$32M	3.31M	+102	+0%	$9.67	Q2 2022
3/31/2022	0.85%		$46.4M	3.31M			$14.02	Q1 2022
12/31/2021	1.15%		$67.6M	3.31M			$20.42	Q4 2021
9/30/2021	0.96%		$61M	3.31M			$18.42	Q3 2021
6/30/2021	1.08%	+1.07%	$62.2M	3.31M	+3,311,434	NEW	$18.77	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.